AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSNKY) announced Wednesday that Enhertu, their jointly developed antibody-drug conjugate, reached the main goal in a Phase 3 trial in certain ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the company is a “little late to join the party.” But just because AZ has ...

pharmaphorum speaks with Steven Davis of AstraZeneca on how the first year of its first direct-to-patient program - ARIMIDEX Direct has been. A year ago, AstraZeneca announced its first direct-to ...

But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...

Zoom cameras on smartphones have changed the way we capture distant subjects, making professional-grade photography more accessible than ever. Whether you're trying to get a close-up shot of a ...

Rockstar Games has blown the lid off a slew of new details on the highly anticipated Grand Theft Auto VI following the release of the game’s second trailer, offering more details on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Da and Uncle Andy dissect the week’s news with sketches, jokes and the occasional song. Answer Me This: Terms and Conditions + Privacy Notice Terms and Conditions ...